---
title: 'Impact of individualized treatment on recovery from fatigue and return to
  work in survivors of advanced stage Hodgkin Lymphoma: results from the randomized
  international GHSG HD18 trial'
date: '2023-12-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38061428/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231208170741&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Individualized first-line treatment in patients with advanced-stage
  HL considerably shortens TTR-F and TTR-W in PET-2 negative patients. Our results
  support the use of response-adapted shortened treatment duration for patients with
  ...'
disable_comments: true
---
CONCLUSIONS: Individualized first-line treatment in patients with advanced-stage HL considerably shortens TTR-F and TTR-W in PET-2 negative patients. Our results support the use of response-adapted shortened treatment duration for patients with ...